Protective effects of morroniside isolated from corni fructus against renal damage in streptozotocin-induced diabetic rats

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 7, 2008, Pages 1422-1428

  Yokozawa, Takako ^a   Yamabe, Noriko ^a   Kim, Hyun Young ^a   Kang, Ki Sung ^a   Hur, Jong Moon ^a   Park, Chan Hum ^a   Tanaka, Takashi ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Diabetic renal damage; Hyperglycemia; Morroniside; Oxidative stress

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CORNUS OFFICINALIS EXTRACT; CREATININE; GLUCOSE; GLYCOSYLATED PROTEIN; HEME OXYGENASE 1; MORRONISIDE; NITROGEN; PROTEIN; SERUM ALBUMIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ALBUMIN BLOOD LEVEL; ARTICLE; CORNUS; CORNUS OFFICINALIS; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RENAL PROTECTION; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CORNUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRINKING; EATING; GLYCOSIDES; GLYCOSYLATION; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; KIDNEY CORTEX; MALE; MITOCHONDRIA; ORGAN SIZE; PROTEINURIA; RATS; RATS, WISTAR; SERUM ALBUMIN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; URODYNAMICS;

EID: 46449130619     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1422     Document Type: Article

References (51)

1. Mau J. L., Chen C. P., Hsieh P. C., J. Agric. Food Chem., 49, 183-188 (2001).
2. Chang J. S., Chiang L. C., Hsu F. F., Lin C. C., Am. J. Chin. Med., 32, 717-725 (2004).
3. Liou S. S., Liu I. M., Hsu S. F., Cheng J. T., J. Pharm. Pharmacol., 56, 1443-1447 (2004).
4. Vareed S. K., Reddy M. K., Schutzki R. E., Nair M. G., Life Sci., 78, 777-784 (2006).
5. Hatano T., Ogawa N., Kira R., Tasuhara T., Okuda T., Chem. Pharm. Bull., 37, 2083-2090 (1989).
6. Wang S. F., Chen X. G., Hu Z. D., Ju Y., Biomed. Chromatogr., 17, 306-311 (2003).
7. Pi W. X., Cai B. C., Xu H. Q., Ye L. H., J. Tradit. Chin. Drug Res. Clin. Pharmacol., 14, 23-24 (2003).
8. Xu H. Q., Hao H. P., Biol. Pharm. Bull., 27, 1014-1018 (2004).
9. Xu H. Q., Hao H. P., Zhang X., Pan Y., Acta Pharmacol. Sin., 25, 412-415 (2004).
10. Xu H., Shen J., Liu H., Shi Y., Li L., Wei M., Can. J. Physiol. Pharmacol., 84, 1267-1273 (2006).
11. Wang W., Huang W., Li L., Ai H., Sun F., Liu C., An Y., Cell. Mol. Neurobiol., doi: 10.1007/s10571-007-9168-7 (2007).
12. Baynes J. W., Diabetes, 40, 405-412 (1991).
13. Ahmed N., Diabetes Res. Clin. Pract., 67, 3-21 (2005).
14. Selby J. V., FitzSimmons S. C., Newman J. M., Katz P. P., Sepe S., Showstack J., JAMA, 263, 1954-1960 (1990).
15. Held P. J., Port F. K., Webb R. L., Wolfe R. A., Garcia J. R., Blagg C. R., Agodoa L. Y., Am. J. Kidney Dis., 18, 1-16 (1991).
16. The Diabetes Control and Complications Trial Research Group, N. Eng. J. Med., 329, 977-986 (1993).
17. Yokozawa T., Yamabe N., Cho E. J., Nakagawa T., Oowada S., Nephron Exp. Nephrol., 97, e38-e48 (2004).
18. Yamabe N., Yokozawa T., J. Pharm. Pharmacol., 58, 535-545 (2006).
19. Nakagawa T., Yokozawa T., Yamabe N., Rhyu D. Y., Goto H., Shimada Y., Shibahara N., J. Pharm. Pharmacol., 57, 1205-1212 (2005).
20. Yamabe N., Yokozawa T., Kim H. Y., Cho E. J., J. Pharm. Pharmacol., 57, 1637-1644 (2005).
21. Kim H. Y., Yokozawa T., Cho E. J., Yamabe N., J. Pharm. Pharmacol., 56, 1299-1305 (2004).
22. Yamabe N., Kang K. S., Goto E., Tanaka T., Yokozawa T., Biol. Pharm. Bull., 30, 520-526 (2007).
23. Yamabe N., Kang K. S., Matsuo Y., Tanaka T., Yokozawa T., Biol. Pharm. Bull., 30, 1289-1296 (2007).
24. Otsuka H., Kijima K., Chem. Pharm. Bull., 49, 699-702 (2001).
25. McFarland K. F., Catalano E. W., Day J. F., Thorpe S. R., Baynes J. W., Diabetes, 28, 1011-1014 (1979).
26. Naito C., Yamanaka T., Nippon Ronen Igakkai Zasshi, 15, 187-191 (1978).
27. Johnson D., Lardy H., Methods Enzymol., 10, 94-96 (1967).
28. Jung K., Pergande M., FEBS Lett., 183, 167-169 (1985).
29. Mihara M., Uchiyama M., Anal. Biochem., 86, 271-278 (1978).
30. Itzhaki R. F., Gill D. M., Anal. Biochem., 9, 401-410 (1964).
31. Goto M., Inoue H., Seyama Y., Yamashita S., Inoue O., Yumioka E., Nippon Yakurigaku Zasshi, 93, 179-186 (1989).
32. Furuya Y., Kawakita T., Tajima S., J. Trad. Med., 16, 123-128 (1999).
33. Yamada T., "Kinki Youryaku," Kyouwa-Kikaku, Tokyo, 1992, pp. 1-7.
34. Huang T., "A Handbook of Traditional Chinese Prescriptions of Dubious and Complicated Cases," China Medical and Pharmaceutical Science and Technology Publishing House, Beijing, 1997, pp. 527-538.
35. Zhu Y. P., "Chinese Materia Medica: Chemistry, Pharmacology and Applications," Harwood Academic Publishers, Amsterdam, 1998, pp. 668-670.
36. Cooper M. E., Gilbert R. E., Epstein M., Metabolism, 47, 3-6 (1998).
37. Yabe-Nishimura C., Pharmacol. Rev., 50, 21-33 (1998).
38. Giugliano D., Ceriello A., Paolisso G., Diabetes Care, 19, 257-267 (1996).
39. Salahudeen A. K., Kanji V., Reckelhoff J. F., Schmidt A. M., Nephrol. Dial. Transplant., 12, 664-668 (1997).
40. Koito W., Araki T., Horiuchi S., Nagai R., J. Biochem., 136, 831-837 (2004).
41. Lieuw-A-Fa M. L. M., van Hinsbergh V. W. M., Teerlink T., Barto R., Twisk J., Stehouwer C. D. A., Schalkwijk C. G., Nephrol. Dial. Transplant., 19, 631-636 (2004).
42. Fu M. X., Requena J. R., Jenkins A. J., Lyons T. J., Baynes J. W., Thorpe S. R., J. Biol. Chem., 271, 9982-9986 (1996).
43. Wendt T., Tanji N., Guo J., Hudson B. I., Bierhaus A., Ramasamy R., Arnold B., Nawroth P. P., Yan S. F., D'Agati V., Schmidt A. M., J. Am. Soc. Nephrol., 14, 1383-1395 (2003).
44. Yeh C. H., Sturgis L., Haidacher J., Zhang X. N., Sherwood S. J., Bjercke R. J., Juhasz O., Crow M. T., Tilton R. G., Denner L., Diabetes, 50, 1495-1504 (2001).
45. Fan Q., Liao J., Kobayashi M., Yamashita M., Gu L., Gohda T., Suzuki Y., Wang L. N., Horikoshi S., Tomino Y., Nephrol. Dial. Transplant., 19, 3012-3020 (2004).
46. Kushiro M., Shikata K., Sugimoto H., Ikeda K., Horiuchi S., Makino H., Nephron, 79, 458-468 (1998).
47. Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Yan S. D., Hofmann M., Yan S. F., Pischetsrieder M., Stern D., Schmidt A. M., J. Biol. Chem., 274, 31740-31749 (1999).
48. Nakamura S., Tachikawa T., Tobita K., Aoyama I., Takayama F., Enomoto A., Niwa T., Am. J. Kidney Dis., 41, S68-S71 (2003).
49. Kruger A. L., Peterson S. J., Schwartzman M. L., Fusco H., McClung J. A., Weiss M., Shenouda S., Goodman A. I., Goligorsky M. S., Kappas A., Abraham N. G., J. Pharmacol. Exp. Ther., 319, 1144-1152 (2006).
50. Nath K. A., Kidney Int., 70, 432-443 (2006).
51. Hayashi K., Haneda M., Koya D., Maeda S., Isshiki K., Kikkawa R., Diabetes Res. Clin. Pract., 52, 85-96 (2001).